Page last updated: 2024-10-22
alfuzosin and Decerebrate Posturing
alfuzosin has been researched along with Decerebrate Posturing in 1 studies
alfuzosin: structure given in first source
Research Excerpts
| Excerpt | Relevance | Reference |
|---|
| "5." | 1.29 | Alfuzosin, a selective alpha 1-adrenoceptor antagonist in the lower urinary tract. ( Gautier, E; Hicks, PE; Langer, SZ; Lechaire, J; Lefèvre-Borg, F; Manoury, P; O'Connor, SE; Pierre, F; Pimoule, C; Schoemaker, H, 1993) |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|
| Lefèvre-Borg, F | 1 |
| O'Connor, SE | 1 |
| Schoemaker, H | 1 |
| Hicks, PE | 1 |
| Lechaire, J | 1 |
| Gautier, E | 1 |
| Pierre, F | 1 |
| Pimoule, C | 1 |
| Manoury, P | 1 |
| Langer, SZ | 1 |
Clinical Trials (1)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status |
|---|
| Randomized, Open-Labeled Study of Prophylactic Vs. Therapeutic Use of Uroxatrol to Determine Improvements in Urinary Morbidity Following Men Undergoing Prostate Brachytherapy[NCT00201630] | Phase 3 | 150 participants | Interventional | 2005-09-30 | Not yet recruiting |
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Other Studies
1 other study available for alfuzosin and Decerebrate Posturing